PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347 | -11.3% | 33,507 | +12.6% | 0.00% | – |
| Q2 2023 | $391 | +30.3% | 29,758 | +11.1% | 0.00% | – |
| Q1 2023 | $300 | +36.4% | 26,795 | +2.6% | 0.00% | – |
| Q4 2022 | $220 | -99.9% | 26,104 | +2.8% | 0.00% | – |
| Q3 2022 | $424,000 | +23.3% | 25,396 | +8.7% | 0.00% | – |
| Q2 2022 | $344,000 | -34.0% | 23,363 | +11.3% | 0.00% | – |
| Q1 2022 | $521,000 | -23.3% | 20,986 | -0.9% | 0.00% | – |
| Q4 2021 | $679,000 | -95.4% | 21,183 | -94.9% | 0.00% | -100.0% |
| Q3 2021 | $14,802,000 | -13.9% | 411,387 | +5.6% | 0.00% | -50.0% |
| Q2 2021 | $17,186,000 | -47.7% | 389,527 | -45.7% | 0.00% | -33.3% |
| Q1 2021 | $32,838,000 | +28.6% | 717,923 | +94.1% | 0.00% | 0.0% |
| Q4 2020 | $25,532,000 | – | 369,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |